Resources from the same session
80MO - Gut microbiome analysis for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer patients
Presenter: Yuxi Yi
Session: Mini oral session on Gastrointestinal tumours 2
Resources:
Abstract
Slides
Webcast
81MO - Clinical experience of a personalized and tumour-informed circulating tumour DNA assay for minimal residual disease detection in oligometastatic colorectal cancer patients
Presenter: Stacey Cohen
Session: Mini oral session on Gastrointestinal tumours 2
Resources:
Abstract
Slides
Webcast
82MO - Automatical risk stratifying for colorectal cancer by deep learning based pathological score
Presenter: Shenlun Chen
Session: Mini oral session on Gastrointestinal tumours 2
Resources:
Abstract
Slides
Webcast
83MO - AMG 510, a novel small molecule inhibitor of KRAS(G12C), for patients (pts) with advanced gastrointestinal (GI) cancers: Results from the CodeBreaK100 phase I trial
Presenter: Timothy Price
Session: Mini oral session on Gastrointestinal tumours 2
Resources:
Abstract
Slides
Webcast
84MO - A phase II, multicenter, open-label study of trastuzumab deruxtecan (T-DXd; DS-8201) in patients with HER2-expressing metastatic colorectal cancer (mCRC): DESTINY-CRC01
Presenter: Takayuki Yoshino
Session: Mini oral session on Gastrointestinal tumours 2
Resources:
Abstract
Slides
Webcast
85MO - Management of adverse events associated with encorafenib plus cetuximab in patients with BRAF V600E mutant metastatic colorectal cancer (BEACON CRC Study)
Presenter: Chang-Fang Chiu
Session: Mini oral session on Gastrointestinal tumours 2
Resources:
Abstract
Slides
Webcast
Invited Discussant abstracts 83MO, 84MO and 85MO
Presenter: Julien Taieb
Session: Mini oral session on Gastrointestinal tumours 2
Resources:
Slides
Webcast
LIVE Q&A
Presenter: Julien Taieb
Session: Mini oral session on Gastrointestinal tumours 2
Resources:
Webcast
LIVE Q&A
Presenter: Julien Taieb
Session: Mini oral session on Gastrointestinal tumours 2
Resources:
Webcast